Epidemiological studies have shown that elevated serum levels of fetuin-A are connected with T2DM, insulin resistance, and NAFLD [62]; however, the relation with liver steatosis is not clear [63]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.